Investing RAD receives IND approval from US FDA for Betabart (RV-01) July 28, 2025 Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01) Download the PDF here. This post appeared first on investingnews.com 0 Prev Post Maiden Drill Program Commences at Oasis Uranium Project July 28, 2025 Next Post S&P 500 Breaking Out Again: What This Means for Your Portfolio July 28, 2025 Related Posts Syntholene Selects Papadakis Engineering as Integration Partner for Novel Thermal-Hybrid Synthetic Fuel Demonstration Facility Heat Exchanger System March 13, 2026 Summit Royalties Announces Agreement to Acquire Royalty on Newmont’s Saddle North Deposit March 13, 2026 Lahontan Announces Private Placement March 13, 2026
Syntholene Selects Papadakis Engineering as Integration Partner for Novel Thermal-Hybrid Synthetic Fuel Demonstration Facility Heat Exchanger System March 13, 2026
Summit Royalties Announces Agreement to Acquire Royalty on Newmont’s Saddle North Deposit March 13, 2026
